Michael Finn



Add to contacts


Michael is a Partner in the Commercial Litigation and Dispute Resolution Department at Matheson.

Michael’s practice focuses on complex domestic and international commercial disputes, contentious intellectual property matters, product liability, regulatory disputes and prosecutions, and judicial review.  He has a particular focus on the life sciences and TMT sectors. He has acted in some of the leading technology disputes in Ireland and has extensive experience advising on Irish Commercial Court litigation, and ADR.

Michael leads the firm’s Intellectual Property Litigation practice, and is a member of the Life Sciences Group.  He advises on a wide range of litigation matters involving patents, trade marks, copyright, designs, trade secrets and confidential information, often involving additional issues such as intermediary liability, data protection, competition and consumer law claims. He also advises clients in relation to the regulation of medicinal products and medical devices in Ireland, and has built up a strong expertise in navigating clients through interactions with regulators, as well as the regulatory impacts of commercial transactions.

Experience Highlights
  • Acted for a leading multinational technology company in the defence of trade mark infringement proceedings in the Commercial Court.
  • Acting for a leading music publishing company in the defence of copyright infringement proceedings.
  • Advising a multinational life sciences company in relation to patent infringement proceedings.
  • Representing clients in relation to High Court and Commercial Court proceedings, including obtaining and defending injunctions, take-down notices and other similar orders.
  • Advising some of the world’s leading technology and AI companies on their advancement into life sciences and med tech.
  • Acted for a global medical device company in the defence of a regulatory investigation, commercial dispute and multiple product liability claims arising from a defective device.
  • Acting for multinational life sciences and medical device companies in a wide range of contentious issues, including the defence of product liability claims, regulatory investigations and commercial disputes.
  • Advising clients on reimbursement applications (and challenges) and price reviews of products supplied under the state-sponsored community drugs schemes, including advising on the largest ever private medicines deal in the history of the State.
  • Advised a leading global medical devices manufacturer on legal action following the withdrawal of ISO certificates by a notified body.
  • Advised multinational companies on submissions to the legislature and stakeholders in relation to draft legislation.

Michael Finn is recommended.
European Legal 500 2019

Michael Finn is "incredibly commercially aware and good at client care".
Life Sciences: Chambers Europe 2019

"Michael Finn impressed me."
Chambers Europe 2018

"Michael thinks outside the box."
Chambers Europe 2018

"Michael is on top of his game."
Chambers Europe 2018

Michael Finn is recommended
Intellectual Property: European Legal 500 2018

Michael Finn is recommended.
Health and Life Sciences: European Legal 500 2018

Pragmatic and knowledgeable’.
Health and Life Sciences: European Legal 500 2018

"A good strategist and a realist."
Chambers Europe 2018

"Versatility across multiple areas of the law, his knowledge of the industry and his ability to communicate in the same language as his clients."
Chambers Europe 2018

Michael Finn is recognised in Who’s Who Legal 2018

Michael “knows the relevant legislation inside out as well as knowing the non-legal industry landscape very well. He is a very approachable and down-to-earth lawyer."
Chambers Europe 2017

Michael Finn is recommended.
European Legal 500 2016


University College Dublin and Universität Hannover, Germany BCL (European Legal Studies)

Solicitor, Law Society of Ireland (Hilary Term, 2007)

Related Practice Areas

About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)